-
Obesity and heart failure: exploring the cardiometabolic axis Cardiovasc. Res. (IF 10.2) Pub Date : 2025-06-03
Jennifer J Rayner, Ines Abdesselam, Jiliu Pan, Andrew J M Lewis, Oliver J RiderObesity is one of the biggest risks to public health in both developed and developing countries, and yet incidence continues to skyrocket. Being the main risk factor for a large number of life-limiting conditions, obesity has the potential to cause enormous damage unless addressed urgently. Heart failure (HF) is the most common cardiovascular disease associated with obesity. The incidence of HF overall
-
A rare gain of function variant of hepatic lipase attenuates hypercholesterolemia and atherosclerosis in mice via an LDL receptor-independent mechanism Cardiovasc. Res. (IF 10.2) Pub Date : 2025-06-03
Thibaud Sotin, Xiaoke Ge, Milena Schönke, Lucie Vince, Amélie Thouzeau, Samuel Frey, Victoria Lorant, Lisa Krul, Amanda C M Pronk, Reshma Lalai, Trea C M Streefland, Salwa Afkir, Wieneke Dijk, Sarra Smati, Marieke Heijink, Niek Blomberg, Martin Giera, Mathilde Di Filippo, Philippe Moulin, Sander Kooijman, Bertrand Cariou, Patrick C N Rensen, Cédric Le MayAims LIPC encodes hepatic lipase (HL), a liver-bound protein with both phospholipase and triglyceride lipase activity, and involved in the catabolism of circulating lipoproteins. We recently identified the gain-of-function variant HL-E97G, with selectively increased phospholipase activity, as a new genetic cause of familial combined hypocholesterolemia in humans. The role of HL in the development of
-
Platelets and inflammation - insights from platelet non-coding RNA content and release in the Bruneck Study and the PACMAN-AMI trial Cardiovasc. Res. (IF 10.2) Pub Date : 2025-06-03
Clemens Gutmann, Temo Barwari, Christian Schulte, Konstantinos Theofilatos, Bhawana Singh, Kaloyan Takov, Gonca Suna, Melissa V Chan, Paul C Armstrong, Christian Cassel, Yasushi Ueki, Jonas D Häner, Peter Santer, Peter Willeit, Christian Hengstenberg, Lorenz Räber, Stefan Kiechl, Johann Willeit, Timothy D Warner, Manuel MayrAims Platelets contain non-coding RNAs (ncRNAs), and their measurement may complement platelet aggregometry. Methods and results In the community-based Bruneck Study (n = 338), we generated platelet-rich plasma (PRP), platelet-poor plasma (PPP) and platelets. PRP was subjected to aggregometry using various agonists and processed to platelet releasates thereafter. Releasates, PPP and platelets underwent
-
Single-cell epigenomic and transcriptomic analysis unveils the pivotal role of GATA5/ISL1+ fibroblasts in cardiac repair post-myocardial infarction Cardiovasc. Res. (IF 10.2) Pub Date : 2025-06-03
Shuchen Zhang, Boyang Xiang, Yiheng Zhao, Wenjing Wang, Lili Chen, Xiang ZhouAims A comprehensive understanding of the genome-wide regulatory landscape of the cardiac tissues post-myocardial infarction (MI) is still lacking. We therefore integrated single-cell RNA sequencing (scRNA-seq) and single-cell for transposase-accessible chromatin sequencing (scATAC-seq) to elucidate the epigenetic landscape of the heart post-MI. Methods and results We established MI mice through ligation
-
Ceramides in cardiovascular disease – emerging role as independent risk predictors and novel therapeutic targets Cardiovasc. Res. (IF 10.2) Pub Date : 2025-06-03
Roland Klingenberg, Andreas Leiherer, Dobromir Dobrev, Juan C Kaski, Bodo Levkau, Winfried März, Samuel Sossalla, Arnold von Eckardstein, Heinz DrexelCeramides are bioactive lipid mediators involved in apoptosis, inflammation, and fibrosis. This narrative review provides a concise overview of the emerging role of ceramides in cardiovascular disease with emphasis on atherosclerotic vascular disease and heart failure, suggesting a potential use of ceramides in risk stratification and as putative therapeutic targets. Recent developments based on observational
-
Adverse cardiac events associated with antibody drug conjugates in cancer patients: a retrospective analysis on the FAERS database and randomized controlled trials Cardiovasc. Res. (IF 10.2) Pub Date : 2025-06-02
Shaowei Zhuang, Bitao Wang, Enmin Wu, Jierong Lin, Wanxian Zeng, Maobai Liu, Jing Yang, Xiujuan ZhangAims Antibody Drug Conjugates(ADCs) are approved for use in cancers. Cardiovascular adverse reaction is a fatal adverse reactions associated with ADCs. The incidence of adverse cardiac events about ADCs have not been fully studied. We aimed to assess differences in cardiotoxicity among cancer patients treated with different ADCs. Methods and Results An observational retrospective pharmacovigilance
-
Targeting CD8+ T cells in cardiovascular diseases - current options and therapeutic perspectives Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-31
Rida Al-Rifai, Vincent Duval, Icia Santos-Zas, Théo Guyon, Luna Chetrit, Corinne Tanchot, Clement Cochain, Alma Zernecke, Marc Vocanson, Benoit Bensaid, Alain Tedgui, Heinz-Peter Schultheiss, Christian Baumeier, Christian Bailly, Hafid Ait-OufellaT lymphocytes expressing the CD8 coreceptor, often referred to as cytotoxic T-lymphocytes (CTL), are critical in defending against virus infections and cancers. CD8 encompasses a diverse family of proteins, including homodimers, heterodimers, isoforms, and splice variants. CD8αβ heterodimers are the predominant form of the CD8 membrane protein, often anchored to lipid rafts to facilitate the activation
-
Sweeteners: erythritol, xylitol and cardiovascular risk - friend or foe? Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-30
Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, Arduino Arduini, Angelo D’Alessandro, Edoardo Gronda, Stefano Carugo, Mario Bonomini, Maurizio Gallieni, Valentina Masola, Anne Angelillo-Scherrer, Tommaso Prosdocimi, Gary D LopaschukHyperglycemia harms vascular health and promotes platelet aggregation. Reducing glucose concentration is crucial, and sugar alcohols may aid this effort. Used for over 50 years in food, cosmetic, and pharmaceutical industries, erythritol and xylitol minimally affect plasma glucose and insulin levels while promoting the release of beneficial gastrointestinal hormones such as e.g. glucagon-like peptide-1
-
PRDM16, a new kid on the block in cardiovascular health and disease Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-29
Jore Van Wauwe, Hannelore Kemps, Pieter Vrancaert, Alexia Mahy, Robin Schellingen, Mandy O J Grootaert, Manu Beerens, Aernout LuttunTranscriptional regulation is essential for the development, homeostasis, and function of all organisms. Transcription factors and epigenetic modifiers play an indispensable role by direct or indirect interaction with DNA or chromatin. Although the role of transcription factor PRDM16 in adipose, hematopoietic, skeletal, and neural cell lineage specification is well-documented, its function within the
-
Decoding calcific aortic valve disease: is liver X receptor the key to lipid metabolism? Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-20
Adrien Lupieri,Elena Aikawa -
Atrial fibrillation: a measure from one circular RNA. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-19
Francesco Ruberto,Roger Foo -
Novel roles of Nrf3-Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-16
Qishan Chen, Shasha Sun, Zhenning Shi, Leyu Wang, Yumeng Wang, Ancheng Zheng, Xiaolei Xu, Mei Yang, Kun Sun, Qingzhong Xiao, Li ZhangAims Neointimal hyperplasia (NIH) characterized by vascular smooth muscle cell (VSMC) dysfunctions plays a critical role in many vascular diseases including atherosclerosis and restenosis, which leads to serious ischemic complications and has limited therapeutic approaches. Our previous studies confirm a critical role for nuclear factor erythroid 2-related factor 3 (Nrf3) in VSMC differentiation. However
-
Deficiency of NPR-C triggers high salt-induced thoracic aortic dissection by impairing mitochondrial homeostasis Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-15
Jin-Qiu Wei, Yi Yang, Wen-Hui Zhai, Jia-Jia Zhao, Yi-Hang Yang, Yuan-Yuan Kang, Qi-Fang Huang, Wei Zhang, Wu-Wei Rong, Qian-Wan Deng, Jing Chen, Xiao-Fei Ye, Ping-Jin Gao, Zhe Wang, Xiao-Dong Li, Ji-Guang WangAims Thoracic aortic dissection (TAD) is a highly fatal disease lacking effective pharmacologic interventions in clinical practice. Emerging evidence indicates that the natriuretic peptide receptor C (NPR-C) plays a crucial role in the regulation of cardiovascular diseases. However, the precise involvement of NPR-C in TAD remains elusive. In this study, the role and molecular mechanisms of NPR-C in
-
The Beating Heart: art meets science in the story of the heart. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-14
Robin P Choudhury -
Endothelial IGF-1 signaling: a conductor of vascular barrier function and LDL trafficking in atherogenesis. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-13
Cong Liu,Joanna M Kalucka -
Proteomic profiling reveals a higher presence of glycolytic enzymes in human atherosclerotic lesions with unfavourable histological characteristics Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-12
Kaylin C A Palm, Xiaoke Yin, Ferheen Baig, Konstantinos Theofilatos, Sander W van der Laan, Gert J de Borst, Dominique P V de Kleijn, Johann Wojta, Stefan Stojkovic, Manuel Mayr, Hester M den Ruijter, Gerard Pasterkamp, Ernest Diez Benavente, Michal MokryAims Molecular characterization of vulnerable atherosclerotic plaques often relies on transcriptomic data. However, RNA expression may not consistently align with protein expression. The proteomic landscape linked to plaque vulnerability is underexplored in human lesions. In this study, we analyzed a large mass spectrometry-based proteomics dataset from the plaque tissue of 320 patients to identify
-
Living myocardial slices: walking the path towards standardization Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-12
Jort S A van der Geest, Teun P de Boer, Cesare M Terracciano, Thomas Thum, Andreas Dendorfer, Pieter A Doevendans, Linda W van Laake, Joost P G Sluijter, Vasco Sampaio-PintoCardiovascular disease remains a persistent global health burden, underscoring the necessity for effective therapeutic strategies. Despite significant advances, the ability to mechanistically study human disease and predict clinical outcomes remains limited, especially in complex diseases such as heart failure. This limitation is evident through the continuous high attrition rates in drug development
-
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: A drug-target Mendelian randomization study Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-10
Eloi Gagnon, Dipender Gill, Jérôme Bourgault, Émilie Gobeil, Patricia L Mitchell, Arnaud Girard, Audrey Paulin, Christian Couture, Yohan Bossé, Sébastien Thériault, Patrick Mathieu, Marie-Claude Vohl, André Tchernof, Kausik K Ray, John J P Kastelein, Benoit J ArsenaultAims RNA interference therapies targeting liver expression of the gene proprotein convertase subtilisin/kexin type 9 (PCSK9) lower low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) levels. As opposed to monoclonal antibodies, which neutralise PCSK9 circulating protein, their effect on atherosclerotic cardiovascular disease (ASCVD) outcomes is unknown. We used genetic variants
-
Atrial remodelling and atrial fibrillation self-sustaining: the role of circulating circDGCR8 Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-08
Yuanfeng Gao, Ying Dong, Nan Jiang, Hanrui Zhang, Zheng Liu, Qianhui Wang, Yuan Fu, Jing Li, Zhiqing Li, Huize Pan, Xianing Zheng, Lingyu Zhan, Xinchun Yang, Li Xu, Mulei ChenAims The prediction of atrial fibrillation (AF) progression and post-ablation recurrence is currently based on empirical estimates, leading to suboptimal predictive accuracy. This study investigates whether atrial remodelling, a key factor in the severity of atrial cardiomyopathy, could serve as a shared substrate influencing both AF progression and recurrence. We aimed to identify circular RNAs (circRNAs)
-
Harnessing the power of the brain to fight metabolic diseases. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-23
Emiel P C van der Vorst,Giuseppe Lembo -
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study - differences and similarities. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-06
Tove Fall,Anders Gummesson,Ulf Hammar,Håkan Ahlström,Oskar Angerås,Anders Blomberg,John Brandberg,Kenneth Caidahl,Elin Chorell,Jan E Engvall,Per Eriksson,David Erlinge,Bruna Gigante,Ola Hjelmgren,Johan Hultdin,Tomas Jernberg,Johan Kihlberg,Lars Lind,Martin Magnusson,Fredrik H Nyström,Carlo Pirazzi,Alexandru Schiopu,Johan Sundström,Stefan Söderberg,Carl Johan Östgren,Gunnar Engström -
The three calmodulin genes - territories defined? Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-02
Marcos Gonzalez,Quang-Kim Tran -
Abdominal aortic aneurysm histomorphology shows different inflammatory aspects among patients and is not associated with classic risk factors—the HistAAA study Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-29
Maja Carina Nackenhorst, Felix Menges, Bianca Bohmann, David Zschäpitz, Christine Bollwein, Sven Flemming, Nadja Sachs, Wolf Eilenberg, Christine Brostjan, Christoph Neumayer, Matthias Trenner, Wiebke Ibing, Hubert Schelzig, Christian Reeps, Lars Maegdefessel, Heinz Regele, Markus Udo Wagenhäuser, Claus Jürgen Scholz, Thomas Christian Gasser, Albert BuschAims Abdominal aortic aneurysm (AAA) treatment is upon a diameter threshold. Attempts for medical growth abrogation have failed thus far. This study aims to elucidate the heterogeneity of AAA histomorphology in correlation with individual patient and aneurysm metrics. Methods and results Samples from the left anterior aneurysm wall underwent histologic analysis including angiogenesis, calcification
-
Distinct intracellular spatiotemporal expression of Calmodulin genes underlies functional diversity of CaM-dependent signaling in cardiac myocytes Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-24
Vladimir Bogdanov, Juan I E Mariangelo, Andrew M Soltisz, Galina Sakuta, Anastasia Pokrass, Casey Beard, Benjamin Hernandez Orengo, Roman Kalinin, Ali Ulker, Bennett Yunker, Svetlana Tikunova, Jenna Thuma, Xianyao Xu, Thomas J Hund, Rengasayee Veeraraghavan, Jonathan P Davis, Sandor GyörkeAims This study aims to resolve the mechanisms underlying Calmodulin (CaM)'s signaling diversity by investigating whether the three CaM genes—Calm1, Calm2, and Calm3—play distinct or redundant roles in cardiac myocytes, focusing on their spatial mRNA localization and interactions with key targets. Methods and Results We utilized single-molecule mRNA detection and 3D imaging to map the spatial distribution
-
A new protein isoform encoded by human circular RNA circSLC8a1 contributes to cardiac remodeling Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-24
Feiya Li, William W Du, Xiangmin Li, Shuoyang Wen, Jindong Xu, Qiwei Yang, Jinfeng Wei, Sheng Wang, Nan Wu, Javeria Qadir, Burton B YangAims Circular RNA circSLC8a1 has been previously suggested to possess translation potential, but experimental evidence supporting this notion has been lacking. We aim to understand the functions of circSLC8a1 and its translated protein in cardiac remodeling. Methods and Results To elucidate the functional significance of circSLC8a1, we established a transgenic mouse line expressing circSLC8a1 and its
-
Identification of pulmonary artery stiffening due to left heart disease by ultrasonography Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-24
Mariya M Kucherenko, Marian Kukucka, Pengchao Sang, Niklas Hegemann, Qiuhua Li, Felix Hennig, Ruhi Yeter, Tara Gransar, Alexander Mladenow, Anna Emmerich, Andrea Orsenigo, Jana Grune, Volkmar Falk, Wolfgang M Kuebler, Christoph KnosallaAims Pulmonary hypertension (PH) is a common complication of left heart disease (LHD) that leads to right heart failure and death. Pulmonary artery (PA) stiffening has recently emerged as an important diagnostic and prognostic parameter in PH. The present study aimed to develop and validate an ultrasonographic index to identify PA stiffening in PH due to left heart disease (PH-LHD). Methods and Results
-
Sex and sex hormonal regulation of the atrial inward rectifier potassium current (IK1): insights into potential pro-arrhythmic mechanisms Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-24
Lucilla Giammarino, Lluis Matas, Nicolò Alerni, András Horváth, Varjany Vashanthakumar, Saranda Nimani, Miriam Barbieri, Sahej Bains, Ruben Lopez, Julien Louradour, Balazs Ördög, Thomas Hof, Ange Maguy, Giulio Conte, Angelo Auricchio, Ulrich Schotten, Katja E OdeningAims Pronounced sex-differences are known in the incidence of atrial fibrillation (AF). In this study, we aimed to investigate the atrial electrophysiological properties that may underlie sex-differences in AF incidence in the younger population, focusing on IK1, a cardiac ion current important for action potential (AP) stability and triggered activity. Methods and Results We assessed sex-differences
-
Sleep protects the heart after myocardial infarction through a neuro-immune axis: time to implement healthy sleep for cardiovascular prevention? Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-23
Fabrizia Bonacina,Daniela Carnevale -
Unravelling inflammation: the critical role of ETS2 in macrophage activation and chronic disease. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-23
Soumaya Ben-Aicha,Gustavo Ramos -
Enhanced intracranial aneurysm development in a rat model of polycystic kidney disease Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-18
Anne F Cayron, Sandrine Morel, Maral Azam, Julien Haemmerli, Tomohiro Aoki, Philippe Bijlenga, Eric Allémann, Brenda R KwakAim Polycystic kidney disease (PKD) patients have a high intracranial aneurysms (IAs) incidence and risk of rupture. The mechanisms that make PKD patients more vulnerable to IA disease are still not completely understood. The PCK rat is a well-known PKD model and has been extensively used to study cyst development and kidney damage. Here, we used this rat model to study IA induction and vulnerability
-
Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-18
Timothy J Aballo, Jiyoung Bae, Wyatt G Paltzer, Emily A Chapman, Andrew J Perciaccante, Melissa R Pergande, Rebecca J Salamon, Dakota J Nuttall, Morgan W Mann, Ying Ge, Ahmed I MahmoudAims Adult mammalian cardiomyocytes have limited regenerative potential, and after myocardial infarction (MI), injured cardiac tissue is replaced with fibrotic scar. In contrast, the neonatal mouse heart possesses a regenerative capacity governed by cardiomyocyte proliferation; however, a metabolic switch from glycolysis to fatty acid oxidation during postnatal development results in loss of this regenerative
-
It is all c-RELative: a new perspective for a member of the nuclear factor kappa B family. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-23
Jonathan O'Connor Miranda,Anthony Parent,Stephanie Lehoux -
Combined circulating microRNA and peptide biomarkers for prognostication in heart failure. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-17
Lee Lee Wong,Hiromi W L Koh,Hyungwon Choi,Ruiyang Zou,Lihan Zhou,Jia Yuen Lim,Dominic C Y Phua,Oi Wah Liew,Jenny P C Chong,Jessica Y X Ng,Siew Pang Chan,Yei-Tsung Chen,Poh Shuan D Yeo,Lieng H Ling,David Sim,Kui Toh G Leong,Hean Y Ong,Fazlur Jaufeerally,Raymond Wong,Ping Chai,Adrian F Low,Mayanna Lund,Gerry Devlin,Richard Troughton,Robert N Doughty,Carolyn S P Lam,Heng Phon Too,Arthur Mark Richards -
Tiny trouble: microplastics, nanoplastics, and their heartfelt impact on cardiovascular health Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-17
Tongyao Zhang, Yajie Liao, Jitao Ling, Jing Zhang, Deju Zhang, Xiaoping Yin, Peng Yu, Xiao LiuMicroplastics and nanoplastics are ubiquitous environmental pollutants that pose significant health risks. Several studies have reported the presence of these particles in various human tissues, including the heart, arterial plaques, and bloodstream of patients undergoing percutaneous coronary interventions. Emerging research suggests an association between these particles and an increased risk of
-
Loss of MRAP2 in MC4R neurons protect from obesity-associated autonomic and cardiovascular dysfunctions Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-17
Deng Fu Guo, Paul A Williams, Alexis Olson, Donald A Morgan, Hussein Herz, Jon Resch, Deniz Atasoy, Harald M Stauss, Julien A Sebag, Kamal RahmouniAims The melanocortin receptor accessory protein 2 (MRAP2), which is abundantly expressed in the brain including the hypothalamus, has emerged as a key regulator of melanocortin-4 receptor (MC4R) activity. We sought to delineate the physiological significance of MRAP2 in MC4R neurons, with a particular focus on autonomic and cardiovascular functions. Methods and Results Selective deletion of MRAP2
-
Spinning the web of platelet tetraspanins under stress. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-17
Madhumita Chatterjee -
Revivifying research on relaxin receptor-targeted therapy for cardiovascular diseases. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-17
Xiao-Jun Du -
The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-16
Carolina Janssen-Telders, Etto C Eringa, Joris R de Groot, Frances S de Man, M Louis HandokoHeart failure with preserved ejection fraction (HFpEF) is a growing global health problem characterized by high morbidity and mortality, with limited effective therapies available. Obesity significantly influences haemodynamic and structural changes in the myocardium and vasculature, primarily through the accumulation and action of visceral adipose tissue. Particularly, epicardial adipose tissue (EAT)
-
Beta 2 adrenergic receptor gene methylation activates innate lymphoid cells to drive hypertension in lymphocyte deficient hosts Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-10
Wei Chen, Sara Perrotta, Liang Xiao, Lorenzo Carnevale, Marwa A Abd-ElDayem, Elizabeth M Hennen, Luis Miguel Rivera-Medina, David M Patrick, Mingfang Ao, Fabio Pallante, Azzurra Zonfrilli, Shilin Zhao, Agnese Migliaccio, Lan Lan, Stefania Fardella, Giuseppe Sciumè, Francesco Mastroiacovo, Giuseppe Lembo, Daniela Carnevale, David G HarrisonAims T cells contribute to hypertension; however, hypertension occurs in settings of T cell deficiency. Methods and results We studied two colonies of T/B cell-deficient RAG-1−/− mice with disparate responses to angiotensin II, being one protected from blood pressure increase and the other one responsive. This difference depends on the capability of hypertensive RAG-1−/− mice to expand natural killer
-
Mimicked immunity: a strategy for targeted nanodrug delivery. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-23
Yapei Zhang,Charles C Hong,Bryan Ronain Smith -
Beat strong, think fast: how brain and heart keep each other in check. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-08
Daniela Carnevale,Costantino Iadecola,Joanna Wardlaw -
Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-04
João P Monteiro, Diptarka Saha, Ana-Mishel Spiroski, Saiba Mahesh, Peter Kaltzis, Abhijit Nadavallil, Vaibhao Janbandhu, Nicholas J Murray, Francesco Severi, Azzurra Laura De Pace, Sandra Sánchez-Esteban, Julie Rodor, Abdelaziz Beqqali, Matthew Bennett, Kevin Stewart, Adrian Thomson, Patrick W F Hadoke, Dyana Markose, John R Wilson-Kanamori, Neil C Henderson, Dónal O’Carroll, Thomas Quertermous, RichardAims The highly conserved long non-coding RNA (lncRNA) MIR505HG has been primarily recognized as a precursor for microRNAs (miR)-424 and miR-503. However, studies have since demonstrated that MIR503HG has distinct functions from its associated miRNAs, playing important roles in cell proliferation, invasion, apoptosis, and differentiation. While these miRNAs are known to influence cardiomyocyte differentiation
-
Keep your guard up: blood-brain barrier protection by empagliflozin after acute ischaemic stroke. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-23
Karin Hochrainer,Ashley Hansen,Lidia Garcia-Bonilla -
Pre-ischaemic empagliflozin treatment attenuates blood–brain barrier disruption via β-catenin mediated protection of cerebral endothelial cells Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-02
Guohao Liu, Yanmei Qiu, Nanlin You, Mengchen Yu, Wenbo Chen, Tao Sun, Zhen Qin, Mengtao Han, Zhiwei Xue, Xiangjun Liang, Bo Mao, Lu Ling, Yanzhao Wu, Wenchen Xing, Quanmeng Liu, Donghai WangAims Microvascular endothelial cells dysfunction can significantly worsen ischaemic stroke outcomes by disrupting tight junctions and increasing the acquisition of adhesion molecules, accelerating blood–brain barrier (BBB) disruption and pro-inflammatory response. The identification of drugs that improve endothelial cell function may be crucial for ischaemic stroke. It has been validated that empagliflozin
-
Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-01
Michael Drozd, Alexander-Francisco Bruns, Nadira Y Yuldasheva, Azhar Maqbool, Hema Viswambharan, Anna Skromna, Natallia Makava, Chew W Cheng, Piruthivi Sukumar, Lauren Eades, Andrew M N Walker, Kathryn J Griffin, Stacey Galloway, Nicole T Watt, Natalie Haywood, Victoria Palin, Nele Warmke, Helen Imrie, Katherine Bridge, David J Beech, Stephen B Wheatcroft, Mark T Kearney, Richard M CubbonAims Progressive deposition of cholesterol in the arterial wall characterizes atherosclerosis, which underpins most cases of myocardial infarction and stroke. Insulin-like growth factor-1 (IGF-1) is a hormone that regulates systemic growth and metabolism and possesses anti-atherosclerotic properties. We asked whether endothelial-restricted augmentation of IGF-1 signaling is sufficient to suppress atherogenesis
-
Tetraspanin CD37 regulates platelet hyperreactivity and thrombosis Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-29
Marcin A Sowa, Carmen Hannemann, Ivan Pinos Cabezas, Elissa Ferreira, Bharti Biwas, Min Dai, Emma M Corr, Macintosh G Cornwell, Kamelia Drenkova, Angela H Lee, Tanya Spruill, Harmony R Reynolds, Judith Hochman, Kelly V Ruggles, Robert A Campbell, Coen van Solingen, Mark D Wright, Kathryn J Moore, Jeffrey S Berger, Tessa J BarrettAim To investigate how psychosocial stress contributes to accelerated thrombosis, focusing on platelet activation and hyperreactivity. The specific objective was to identify novel platelet regulators involved in stress-mediated thrombosis, with a particular emphasis on the tetraspanin CD37. Methods and Results To explore how stress contributes to platelet hyperreactivity, platelets were isolated from
-
A paradigm shift in cardiovascular research: new method isolates intestinal interstitial fluid to understand gut microbiome and host cross-talk. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-23
Fadi J Charchar,Francine Z Marques -
It takes more than omics to identify a cardioprotective mechanism. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-24
Gerd Heusch,Petra Kleinbongard -
Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-23
Nivethitha Manickam, Ibrahim Sultan, Josefine Panthel, Haris Kujundzic, Ariane Fischer, Katja Schmitz, Mariano Ruz Jurado, David Rodriguez Morales, David John, Simone-Franziska Glaser, Kathrin A Stilz, Pedro Felipe Malacarne, Ralf Peter Brandes, Thomas Braun, Carolin Lerchenmüller, Fynn Betge, Wesley T Abplanalp, Kari Alitalo, Stefanie Dimmeler, Julian U G WagnerAim Members of the VEGF family are crucial modulators of vascular and neural function. While VEGFA signaling has been shown to mitigate several aging-related cardiac phenotypes and prolong survival in aged mice, the role of VEGFB in cardiac aging remains underexplored. In this study, we identify a significant decline in Vegfb expression, particularly of its soluble isoform Vegfb186, in aged mouse and
-
From mice to humans: advancing the path to cardioprotection. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-23
Lina Badimon,Gemma Vilahur,Guiomar Mendieta -
Biologically engineered valved conduits for right ventricular outflow tract repair evaluated for 52 weeks in growing lambs Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-19
Zeeshan H Syedain, Matthew Lahti, James Berry, John P Carney, Jill Schappa Faustich, Bee Haynie, Jack Maher, Richard Bianco, Gurumurthy Hiremath, John E Mayer, Robroy MacIver, Robert T TranquilloAims Replacement heart valves that grow with children remain an unmet need. We previously reported valves fabricated from tubes of fibroblast-derived collagenous matrix increased in size while functioning with low systolic gradients and less than moderate regurgitation over 52 weeks in most cases, when implanted as interpositional grafts in the pulmonary artery of lambs. Here, we evaluated valved conduits
-
Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-18
Maciej Banach, Stanisław Surma, Tomasz J Guzik, Peter E Penson, Michael J Blaha, Fausto J Pinto, Laurence S SperlingDespite three decades of using statin therapy, 20 years of experience with ezetimbe, and availability of innovative non-statin lipid lowering therapies (LLT), there are still about 70% patients over the low-density lipoprotein cholesterol (LDL-C) goal, with every 5-6th being over the target from the group of very high and extremely high cardiovascular disease (CVD) risk patients. Adding another even
-
Protective functions of liver X receptor α on calcified aortic valve: involvement of regulating endoplasmic reticulum-mediated osteogenic differentiation Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-15
Lishan Zeng, Xin Chen, Kai Kang, Yifei Lin, Zhongxing Zhou, Shuaijie Chen, Chunkai Huang, Qingqing Lin, Hongzhuang Wang, Longqing Chen, Liangliang Yan, HanFan Qiu, Jinxiu Lin, Xiaoyan Lin, Dajun ChaiAims Effective therapeutic drugs for calcific aortic valve disease (CAVD) are lacking, although its incidence has been increasing over the past decade, and is predicted to continue rising in the future. This study aimed to explore the role and potential mechanisms of liver X receptor α (LXRα) in CAVD, which offers a promising approach for treating CAVD. Methods and results Osteogenic stimulation was
-
Blood pressure and the brain: the conundrum of hypertension and dementia. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-04-08
Rebecca F Gottesman,Marco Egle,Renee C Groechel,Amreen MughalAs the population ages, the anticipated rates of dementia worldwide are likely to increase dramatically, especially in low- and middle-income countries; thus, any opportunity to modify dementia risk is especially critical. Hypertension is one risk factor that is highly prevalent, consistently important for late-life brain health, and which could represent a target for prevention of dementia. Furthermore
-
Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-14
Sean M Davidson, Ioanna Andreadou, Charalambos Antoniades, Jozef Bartunek, Cristina Basso, Bianca J J M Brundel, Robert A Byrne, Gemma Chiva-Blanch, Paula da Costa Martins, Paul C Evans, Henrique Girão, Zoltan Giricz, Can Gollmann-Tepeköylü, Tomasz Guzik, Mariann Gyöngyösi, Norbert Hübner, Michael Joner, Petra Kleinbongard, Thomas Krieg, Elisa Liehn, Rosalinda Madonna, Ange Maguy, Melanie PaillardAnimal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples—such as whole blood or fractions, valvular and vascular tissues, myocardium, pericardium, or human-derived cells—is essential for enhancing the translational relevance
-
Unveiling the role of tyrosine kinases in doxorubicin-induced cardiotoxicity and beyond. Cardiovasc. Res. (IF 10.2) Pub Date : 2025-05-06
Edoardo Lazzarini,Claudia Altomare,Lucio Barile -
Cardiac ischemia/reperfusion increases cardiomyocyte KLF5 in pigs and mice that aggravates tissue injury and remodeling Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-13
Nikolaos Mylonas, Georgios Siokatas, Effimia Zacharia, Christine Pol, Tyler Rolland, Ioannis D Kyriazis, Matthew Hoffman, Alycia Hildebrand, Thomas Bannister, Erhe Gao, Ira J Goldberg, Vincent W Yang, Agnieszka B Bialkowska, John Elrod, John M Canty, Ioanna Andreadou, Brian Weil, Konstantinos DrosatosAims Activation of the transcriptional factor Krüppel-like factor 5 (KLF5) is detrimental to chronic heart failure. We explored the involvement of KLF5 in myocardial ischemia/reperfusion injury. Methods and results Yorkshire pigs underwent 75΄ of ischemia, followed by 3h or 24h of reperfusion. C57BL/6J mice underwent 30΄ of ischemia, followed by 10’, 2h, 12h, 24h, or 4 weeks of reperfusion. Hearts
-
Antisense-mediated regulation of exon usage in the elastic spring region of Titin modulates sarcomere function Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-05
Selvi Celik, Ludvig Hyrefelt, Tomasz Czuba, Yuan Li, Juliana Assis, Julia Martinez, Markus Johansson, Oscar André, Jane Synnergren, Joakim Sandstedt, Pontus Nordenfelt, Kristina Vukusic, J Gustav Smith, Olof GidlöfBackground Alternative splicing of Titin (TTN) I-band exons produce protein isoforms with variable size and elasticity, but the mechanisms whereby TTN splice factors regulate exon usage and thereby determining cardiomyocyte passive stiffness and diastolic function, is not well understood. Non-coding RNA transcripts from the antisense strand of protein-coding genes have been shown to regulate alternative
-
Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodeling Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-05
Qing Chen, Yang Yu, Lei Tong, Robert M Weiss, Shun-Guang WeiAims The potential of nanoparticles as effective drug delivery tools for treating failing hearts in heart failure remains a challenge. Leveraging the rapid infiltration of neutrophils into infarcted hearts after myocardial infarction (MI), we developed a nanoparticle platform engineered with neutrophil-membrane proteins for the targeted delivery of TAPI-1, a TACE/ADAM17 inhibitor, to the inflamed myocardium
-
Targeting the PDK/PDH axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation Cardiovasc. Res. (IF 10.2) Pub Date : 2025-03-05
S Griepke, A Grentzmann, G L Tripodi, J Hansen, M P Fonseca, M D Nilsson, Y Tallouzi, E Grupe, P S Jensen, H C Beck, G Temprano-Sagrera, M Sabater-Lleal, M Burton, M Dembic, M Thomassen, M J Forteza, M G Terp, J S Lindholt, L M Rasmussen, L B Steffensen, J Stubbe, D F J KetelhuthAims Abdominal aortic aneurysm (AAA) is a life-threatening condition where inflammation plays a key role. Currently, AAA treatment relies exclusively on surgical interventions, and no guideline drug therapy to prevent aneurysm growth or rupture is available. Pharmacological reprogramming of immune cell metabolism, through the modulation of the pyruvate dehydrogenase kinase/pyruvate dehydrogenase (PDK/PDH)